<DOC>
	<DOC>NCT01518257</DOC>
	<brief_summary>This study will evaluate the efficacy and safety of a single intra-articular (IA) injection of botulinum toxin Type A compared with placebo as treatment for osteoarthritis (OA) knee pain.</brief_summary>
	<brief_title>Safety and Efficacy Study of Botulinum Toxin Type A as Treatment for Osteoarthritis Knee Pain</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Botulinum Toxins, Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Painful osteoarthritis in the study knee Able to walk without assistive walking devices, able to perform usual daily activities, and agree to maintain similar activity level throughout the study Chronic pain conditions other than knee osteoarthritis Presence of bursitis, meniscus tear, ligament tear, or significant injury to the study knee within 1 year Surgery to the study knee within 24 weeks Treatment with hyaluronic acid in the study knee within 24 weeks Treatment with corticosteroids in the study knee within 12 weeks Diagnosis of myasthenia gravis, EatonLambert syndrome, or amyotrophic lateral sclerosis Previous treatment with botulinum toxin of any serotype for any reason</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>